Education
About Us
Working with TipRanks
Follow Us
Towa Pharmaceutical Co Ltd (JP:4553)
:4553
4553 Stock Chart & Stats
¥3655.00
-¥90.00(-2.71%)
At close: 4:00 PM EST
¥3655.00
-¥90.00(-2.71%)
Day’s Range― - ―
52-Week Range¥2,298.00 - ¥3,520.00
Previous CloseN/A
Volume116.60K
Average Volume (3M)112.31K
Market Cap
¥180.37B
Enterprise Value¥332.01B
Total Cash (Recent Filing)¥49.58B
Total Debt (Recent Filing)¥236.26B
Price to Earnings (P/E)8.7
Beta0.74
Next Earnings
Feb 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.18%
Share Statistics
EPS (TTM)115.80
Shares Outstanding51,516,000
10 Day Avg. Volume138,760
30 Day Avg. Volume112,306
Financial Highlights & Ratios
PEG Ratio0.40
Price to Book (P/B)0.77
Price to Sales (P/S)0.51
P/FCF Ratio-24.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)333.28
Revenue Forecast (FY)¥278.87B
Towa Pharmaceutical Co News
4553 FAQ
What was Towa Pharmaceutical Co Ltd’s price range in the past 12 months?
Towa Pharmaceutical Co Ltd lowest stock price was ¥2298.00 and its highest was ¥3520.00 in the past 12 months.
What is Towa Pharmaceutical Co Ltd’s market cap?
Towa Pharmaceutical Co Ltd’s market cap is ¥180.37B.
When is Towa Pharmaceutical Co Ltd’s upcoming earnings report date?
Towa Pharmaceutical Co Ltd’s upcoming earnings report date is Feb 16, 2026 which is in 58 days.
How were Towa Pharmaceutical Co Ltd’s earnings last quarter?
Towa Pharmaceutical Co Ltd released its earnings results on Nov 10, 2025. The company reported ¥115.8 earnings per share for the quarter, beating the consensus estimate of ¥62.021 by ¥53.779.
Is Towa Pharmaceutical Co Ltd overvalued?
According to Wall Street analysts Towa Pharmaceutical Co Ltd’s price is currently Overvalued.
Does Towa Pharmaceutical Co Ltd pay dividends?
Towa Pharmaceutical Co Ltd pays a Semiannually dividend of ¥40 which represents an annual dividend yield of 2.18%. See more information on Towa Pharmaceutical Co Ltd dividends here
What is Towa Pharmaceutical Co Ltd’s EPS estimate?
Towa Pharmaceutical Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Towa Pharmaceutical Co Ltd have?
Towa Pharmaceutical Co Ltd has 51,516,000 shares outstanding.
What happened to Towa Pharmaceutical Co Ltd’s price movement after its last earnings report?
Towa Pharmaceutical Co Ltd reported an EPS of ¥115.8 in its last earnings report, beating expectations of ¥62.021. Following the earnings report the stock price went up 0.323%.
Which hedge fund is a major shareholder of Towa Pharmaceutical Co Ltd?
Currently, no hedge funds are holding shares in JP:4553
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Towa Pharmaceutical Co Ltd
Towa Pharmaceutical Co., Ltd. (4553) is a Japan-based company primarily engaged in the pharmaceutical industry. The company focuses on the development, manufacturing, and marketing of generic pharmaceuticals, as well as ethical drugs. Towa operates in several therapeutic areas, including cardiovascular, oncology, and infectious diseases, providing a range of products to healthcare providers and patients. The company also invests in research and development to enhance its product offerings and expand its market presence in both domestic and international markets.
Technical Analysis
Kaken Pharmaceutical Co
―
Kissei Pharmaceutical Co
―
Torii Pharmaceutical Co
―
KYORIN Pharmaceutical Co.,Ltd.
―
SAWAI GROUP HOLDINGS Co., Ltd.
―
Options Prices
Currently, No data available
---